Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer

Summary

The purpose of this study is to determine whether Betamarc is effective in improving the appetite and reversing weight loss in patients with advanced Non-Small Cell Lung Cancer.

Timeline

Start

2007-10

Primary completion

2008-06

Completion

2008-08

Outcome

Outcome not reported

Stopped: “Objectives of study could not be met within a reasonable timeframe.”

Drugs

Indications